This review examines the evolution, current status, and future potential of minimally invasive glaucoma surgeries (MIGS), a significant advancement in the treatment of glaucoma, a leading cause of irreversible blindness. MIGS offer a less invasive alternative to traditional glaucoma surgeries, primarily aimed at reducing intraocular pressure, minimizing tissue trauma, and providing a safer profile. With the emergence of devices such as the Trabectome, iStent, and others, MIGS have expanded the surgical toolkit, allowing personalized, patient-centered care. Despite their advantages, MIGS face challenges such as efficacy in severe cases, long-term data, and accessibility. Ongoing research and technological innovations continue to refine their capabilities and applications, promising to further transform glaucoma management and patient outcomes. This paper provides an in-depth analysis of MIGS, reflecting on their impact and contemplating future directions in this dynamically evolving field.
Keywords: complex glaucoma & cataract surgeries; diagnostic techniques < glaucoma preventive medicine/screening < socioeconomics and education in medicine/ophthalmology trauma socioeconomics and education in medicine/ophthalmology; glaucoma drainage device; glaucoma surgery; glaucoma treatment; medical retina and glaucoma; migs device; minimally invasive glaucoma surgery; primary open angle glaucoma.
Copyright © 2024, Cheema et al.